Clinical trial Recruiting at 1 site Interventional

Creating a DNA bank for congenital heart disease in southeastern France

Official title: Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic Pathways

Run by Assistance Publique Hopitaux De Marseille · NCT02923440 · Data updated 2026-11-12

This study is creating a DNA bank for people with congenital heart defects in southeastern France to help understand the genetic causes of these conditions better.

More Heart Defects, Congenital trials

Quick facts

Study typeInterventional
SexAll
Enrollment300 (estimated)
SponsorAssistance Publique Hopitaux De Marseille
Academic / other
Locations1 site (Marseille)
StatusRecruiting
StartedJanuary 17, 2017
Main results expectedJanuary 2028
Study endsMarch 2028
Registry record updatedMarch 13, 2023
Trial IDNCT02923440 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include newborns diagnosed with congenital heart defects who require a blood test as part of their medical care.

Probably not a fit

Patients who are pregnant or those unable to provide informed consent due to mental or physical incapacity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to establish a comprehensive DNA bank specifically for patients with congenital heart defects in the south-eastern region of France. By collecting blood samples from affected individuals, the study seeks to enhance the understanding of the genetic pathways involved in these conditions. The initiative addresses the lack of local resources for genetic research and aims to facilitate better diagnosis and classification of congenital heart diseases. The study will utilize the existing infrastructure at the Assistance Publique Hopitaux de Marseille for sample collection and analysis.

Why it matters

Potential benefit: If successful, this initiative could lead to improved genetic understanding and management of congenital heart defects, ultimately benefiting affected patients.

How similar studies have gone: While similar DNA banks have been established in other regions, this specific initiative is novel for the south-eastern region of France.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Echocardiographic diagnosis of congenital heart defect falling within the classification Houyel and Bonnet
* Necessity of making a blood test regardless of study
* Medical care in the AP-HM Timone Hospital children, medical-surgical unit of pediatric and congenital cardiology, Marseille - These Parent Child

Exclusion Criteria:

* Pregnant women
* Patients or parent / legal guardian (if minor) in physical or mental incapacity to understand or sign the consent
* People in Emergencies
* Persons deprived of freedom
* Persons not beneficiaries of a social security scheme
* Persons in health or social institution

Where it's running

  • Assistance Publique Hopitaux de Marseille
    Marseille, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.